Abbott’s HPV test approved for use in Canada
MISSISSAUGA, ONT. | Abbott says it has been granted licence by the Medical Device Bureau of Health Canada for its RealTime High Risk HPV molecular diagnostic test for the detection of human papillomavirus (HPV), the leading cause of cervical cancer.